Skip to main content
OpenTrials

Clinical trial condition

Solid Tumors

Explore clinical trials studying Solid Tumors. Study availability and eligibility vary by location and protocol.

601 public trials 90 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumors trial results

Recruiting

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

NCT06431594

Conditions
Neoplasms, Solid Tumors
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Fountain Valley, California, United States
  • GSK Investigational Site Santa Rosa, California, United States
  • GSK Investigational Site Lake Mary, Florida, United States
View all 65 locations
View Trial Details
Recruiting

A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer

NCT06636435

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +21 more
Locations
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • Kanagawa Cancer Center Yokohama, Kanagawa, Japan
  • Niigata University Medical and Dental Hospital Niigata, Japan
  • National Cancer Center Hospital Chūō, Tokyo, Japan
View Trial Details
Recruiting

JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation

NCT06386146

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Research Site Denver, Colorado, United States
  • Research site Lake Mary, Florida, United States
  • Research site St Louis, Missouri, United States
  • Research site Canton, Ohio, United States
View all 15 locations
View Trial Details
Recruiting

QTX3034 in Patients With KRAS G12D Mutation

NCT06227377

Conditions
Solid Tumors
Locations
  • UCLA Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon Research Institute (SCRI) Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 14 locations
View Trial Details

Related conditions